PGI32 EVALUATION OF THE COST-UTILITY OF THE YORK FAECAL CALPROTECTIN CARE PATHWAY

A previous health economics analysis evaluating the cost-effectiveness of the York Faecal Calprotectin Care Pathway (YFCCP) indicated that YFCCP is cost saving and of clinical benefit when compared with both published data for erythrocyte sedimentation rate (ESR) and c-reactive protein (CRP) testing, and with FC testing using a standard <50ug/g cut-off. However, the results indicated a trade-off when compared with published data from NICE...